InsidersTradesSigma
Follow the 하스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 하스 has recorded 11 reports. The latest transaction was filed on 1 September 2025 (Purchase). Among the most active insiders: 김용수. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
하스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.